581 related articles for article (PubMed ID: 15872347)
21. F-18 FDG PET/CT in the diagnosis of fever of unknown origin.
Balink H; Collins J; Bruyn GA; Gemmel F
Clin Nucl Med; 2009 Dec; 34(12):862-8. PubMed ID: 20139818
[TBL] [Abstract][Full Text] [Related]
22. Incidental PET/CT findings in the cancer patient: how should they be managed?
Beatty JS; Williams HT; Aldridge BA; Hughes MP; Vasudeva VS; Gucwa AL; David GS; Lind DS; Kruse EJ; McLoughlin JM
Surgery; 2009 Aug; 146(2):274-81. PubMed ID: 19628085
[TBL] [Abstract][Full Text] [Related]
23. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.
Imani F; Agopian VG; Auerbach MS; Walter MA; Imani F; Benz MR; Dumont RA; Lai CK; Czernin JG; Yeh MW
J Nucl Med; 2009 Apr; 50(4):513-9. PubMed ID: 19289420
[TBL] [Abstract][Full Text] [Related]
24. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results.
Kamel EM; Thumshirn M; Truninger K; Schiesser M; Fried M; Padberg B; Schneiter D; Stoeckli SJ; von Schulthess GK; Stumpe KD
J Nucl Med; 2004 Nov; 45(11):1804-10. PubMed ID: 15534047
[TBL] [Abstract][Full Text] [Related]
25. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
Wu ZJ; Zhang YX; Wei H; Jia Q
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
[TBL] [Abstract][Full Text] [Related]
26. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
[TBL] [Abstract][Full Text] [Related]
27. F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas.
Iagaru A; Quon A; McDougall IR; Gambhir SS
Clin Nucl Med; 2006 Dec; 31(12):754-60. PubMed ID: 17117068
[TBL] [Abstract][Full Text] [Related]
28. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Du Y; Cullum I; Illidge TM; Ell PJ
J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
[TBL] [Abstract][Full Text] [Related]
29. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Flusser G; Zuriel L; Kollender Y; Lerman H; Lievshitz G; Ron I; Mishani E
J Nucl Med; 2004 Feb; 45(2):272-8. PubMed ID: 14960647
[TBL] [Abstract][Full Text] [Related]
30. Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET.
Yeung HW; Grewal RK; Gonen M; Schöder H; Larson SM
J Nucl Med; 2003 Nov; 44(11):1789-96. PubMed ID: 14602861
[TBL] [Abstract][Full Text] [Related]
31. Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions.
Shammas A; Lim R; Charron M
Radiographics; 2009; 29(5):1467-86. PubMed ID: 19755606
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
Kim BS; Kim IJ; Kim SJ; Pak K; Kim K
Onkologie; 2011; 34(6):298-303. PubMed ID: 21625182
[TBL] [Abstract][Full Text] [Related]
33. Incidental gastrointestinal 18F-Fluorodeoxyglucose uptake associated with lung cancer.
Vella-Boucaud J; Papathanassiou D; Bouche O; Prevost A; Lestra T; Dury S; Vallerand H; Perotin JM; Launois C; Boissiere L; Brasseur M; Lebargy F; Deslee G
BMC Pulm Med; 2015 Dec; 15():152. PubMed ID: 26630933
[TBL] [Abstract][Full Text] [Related]
34. Combined CT colonography and 18F-FDG PET of colon polyps: potential technique for selective detection of cancer and precancerous lesions.
Gollub MJ; Akhurst T; Markowitz AJ; Weiser MR; Guillem JG; Smith LM; Larson SM; Margulis AR
AJR Am J Roentgenol; 2007 Jan; 188(1):130-8. PubMed ID: 17179355
[TBL] [Abstract][Full Text] [Related]
35. Incidental finding of focal FDG uptake in the bowel during PET/CT: CT features and correlation with histopathologic results.
Kei PL; Vikram R; Yeung HW; Stroehlein JR; Macapinlac HA
AJR Am J Roentgenol; 2010 May; 194(5):W401-6. PubMed ID: 20410385
[TBL] [Abstract][Full Text] [Related]
36. Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: results of a prospective study.
Peng J; He Y; Xu J; Sheng J; Cai S; Zhang Z
Colorectal Dis; 2011 Nov; 13(11):e374-8. PubMed ID: 21831098
[TBL] [Abstract][Full Text] [Related]
37. Unexpected foci of 18F-FDG uptake in the breast detected by PET/CT: incidence and clinical significance.
Litmanovich D; Gourevich K; Israel O; Gallimidi Z
Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1558-64. PubMed ID: 19407999
[TBL] [Abstract][Full Text] [Related]
38. The clinical value of incidental 18F-fluorodeoxyglucose-avid foci detected on positron emission tomography/computed tomography.
Ozkol V; Alper E; Aydin N; Ozkol HF; Topal NB; Akpinar AT
Nucl Med Commun; 2010 Feb; 31(2):128-36. PubMed ID: 19858768
[TBL] [Abstract][Full Text] [Related]
39. Physiology and pathophysiology of incidental findings detected on FDG-PET scintigraphy.
Liu Y; Ghesani NV; Zuckier LS
Semin Nucl Med; 2010 Jul; 40(4):294-315. PubMed ID: 20513451
[TBL] [Abstract][Full Text] [Related]
40. Thyroid incidentalomas on FDG PET/CT in patients with non-thyroid cancer - a large retrospective monocentric study.
Kim H; Kim SJ; Kim IJ; Kim K
Onkologie; 2013; 36(5):260-4. PubMed ID: 23689220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]